CD28 and neoplasm: The same group has recently presented preliminary findings of synergistic T-cell-induced tumor cell cytotoxicity in mouse pancreatic cancer cell lines cocultured with OVA-specific CD4+ and CD8+ T-cells transduced with a PD-1-CD28 fusion receptor [40].